The team examined the first four trials, which lasted 68 weeks between 2018 and 2020, and STEP 5, which lasted 104 weeks between 2018 and 2021
Improved Blood Sugar Control: These peptides help regulate blood glucose levels, making them beneficial for individuals with type 2 diabetes or insulin resistance
Activation of both GIP and GLP-1 receptors by retatrutide probably contributed to the observed changes in circulating triglycerides, as treatment with the dual GIP/GLP-1 receptor agonist tirzepatide significantly reduced triglyceride levels by up to 29% at 52 weeks in a clinical trial in people with T2D and MASLD 8
Depending on your skin concerns and health goals, you can begin taking glutathione in your early teens, twenties, or later in life
The absence of a formal contraindication does not eliminate clinical nuance
it means your body has adjusted to a new set point